Literature DB >> 11791902

Use of collagen sponge incorporating transforming growth factor-beta1 to promote bone repair in skull defects in rabbits.

Hiroki Ueda1, Liu Hong, Masaya Yamamoto, Keiji Shigeno, Masatoshi Inoue, Toshinari Toba, Makoto Yoshitani, Tatsuo Nakamura, Yasuhiko Tabata, Yasuhiko Shimizu.   

Abstract

The objective of this study was to evaluate the potential of collagen sponge incorporating transforming growth factor-beta1 (TGF-beta1) to enhance bone repair. The collagen sponge was prepared by freeze-drying aqueous foamed collagen solution. Thermal cross-linking was performed in a vacuum at 140 degrees C for periods ranging from 1 to 48 h to prepare a number of fine collagen sponges. When collagen sponges incorporating 125I-labeled TGF-beta1 were placed in phosphate-buffered saline (PBS) solution at 37 degrees C, a small amount of TGF-beta1 was released for the first hour, but no further release was observed thereafter, irrespective of the amount of cross-linking time the sponges had received. Collagen sponges incorporating 125I-labeled TGF-beta1 or simply labeled with 125I were implanted into the skin on the backs of mice. The radioactivity of the 125I-labeled TGF-beta1 in the collagen sponges decreased with time; the amount of TGF-beta1 remaining dependent on the cross-linking time. The in vivo retention of TGF-beta1 was longer in those sponges that had been subjected to longer cross-linking times. The in vivo release profile of the TGF-beta1 was matched with the degradation profile of the sponges. Scanning electron microscopic observation revealed no difference in structure among sponges subjected to different cross-linking times. The TGF-beta1 immobilized in the sponges was probably released in vivo as a result of sponge biodegradation because TGF-beta1 release did not occur in in vitro conditions in which sponges did not degrade. We applied collagen sponges incorporating 0.1 microg of TGF-beta1 to skull defects in rabbits in stress-unloaded bone situations. Six weeks later, the skull defects were covered by newly formed bone, in marked contrast to the results obtained with a TGF-beta1 free empty collagen sponge and 0.1 microg of free TGF-beta1. We concluded that the collagen sponges were able to release biologically active TGF-beta1 and were a promising material for bone repair.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11791902     DOI: 10.1016/s0142-9612(01)00211-3

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  19 in total

Review 1.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

2.  In vitro cell response on CP-Ti surfaces functionalized with TGF-β1 inhibitory peptides.

Authors:  Pablo Sevilla; Andrea Cirera; Javier Dotor; Francisco Javier Gil; Pablo Galindo-Moreno; Conrado Aparicio
Journal:  J Mater Sci Mater Med       Date:  2018-05-23       Impact factor: 3.896

3.  Heparin-functionalized collagen matrices with controlled release of basic fibroblast growth factor.

Authors:  J M Wu; Y Y Xu; Z H Li; X Y Yuan; P F Wang; X Z Zhang; Y Q Liu; J Guan; Y Guo; R X Li; H Zhang
Journal:  J Mater Sci Mater Med       Date:  2010-11-04       Impact factor: 3.896

4.  Binding and release characteristics of insulin-like growth factor-1 from a collagen-glycosaminoglycan scaffold.

Authors:  Leanne M Mullen; Serena M Best; Roger A Brooks; Siddhartha Ghose; Jessica H Gwynne; John Wardale; Neil Rushton; Ruth E Cameron
Journal:  Tissue Eng Part C Methods       Date:  2010-05-22       Impact factor: 3.056

5.  Engineering fibrin-binding TGF-β1 for sustained signaling and contractile function of MSC based vascular constructs.

Authors:  Mao-Shih Liang; Stelios T Andreadis
Journal:  Biomaterials       Date:  2011-08-23       Impact factor: 12.479

6.  Low-level laser therapy (780 nm) combined with collagen sponge scaffold promotes repair of rat cranial critical-size defects and increases TGF-β, FGF-2, OPG/RANK and osteocalcin expression.

Authors:  Lana Sarita de Souza de Oliveira; Aurigena Antunes de Araújo; Raimundo Fernandes de Araújo Júnior; Carlos Augusto Galvão Barboza; Boniek Castillo Dutra Borges; José Sandro Pereira da Silva
Journal:  Int J Exp Pathol       Date:  2017-05-29       Impact factor: 1.925

7.  Local administration of TGF-beta1 to reinforce the anterior abdominal wall in a rat model of incisional hernia.

Authors:  M Korenkov; N Yuecel; J Koebke; J Schierholz; Ch Morsczeck; I Tasci; E A M Neugebauer; M Nagelschmidt
Journal:  Hernia       Date:  2005-05-24       Impact factor: 4.739

8.  In vitro osteogenic differentiation of adipose stem cells after lentiviral transduction with green fluorescent protein.

Authors:  Qian Wang; Megan B Steigelman; John A Walker; Shuo Chen; Peter J Hornsby; Mary E Bohnenblust; Howard T Wang
Journal:  J Craniofac Surg       Date:  2009-11       Impact factor: 1.046

9.  In vivo degradation of three-dimensional silk fibroin scaffolds.

Authors:  Yongzhong Wang; Darya D Rudym; Ashley Walsh; Lauren Abrahamsen; Hyeon-Joo Kim; Hyun S Kim; Carl Kirker-Head; David L Kaplan
Journal:  Biomaterials       Date:  2008-05-27       Impact factor: 12.479

Review 10.  Treatment of articular cartilage lesions of the knee.

Authors:  Mazen Falah; Gabreil Nierenberg; Michael Soudry; Morris Hayden; Gershon Volpin
Journal:  Int Orthop       Date:  2010-02-18       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.